Promotions & Moves

Cytovance Biologics Names Bioprocess Development VP

Dr. Mott brings more than 30 years of experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. John Mott has been appointed vice president of Bioprocess Development, Cytovance Biologics. Dr. Mott has more than 30 years of experience with bacterial protein expression and more than 15 years of experience with CHO-based protein expression and production. Prior to joining the company, he served in research and leadership positions at Pharmacia and Pfizer, and most recently, as vice president of lab services at Aragen Biosciences. He has led numerous industry alliances to explore and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters